{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:31:10Z","timestamp":1792099870992,"version":"4.4.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ccell.2024.05.026","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T10:40:38Z","timestamp":1718880038000},"page":"1185-1201.e14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["IRF4 requires ARID1A to establish plasma cell identity in multiple myeloma"],"prefix":"10.1016","volume":"42","author":[{"given":"Arnold","family":"Bolomsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Ceribelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Scheich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Papiya","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisette","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George W.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaewoo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Phelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald J.","family":"Holewinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorkell","family":"Andresson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Wisniewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Pittaluga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig J.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagan","family":"Muppidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5866-6126","authenticated-orcid":false,"given":"Ryan M.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2024.05.026_bib1","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/ajh.26590","article-title":"Multiple myeloma: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Rajkumar","year":"2022","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ccell.2024.05.026_bib2","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/leu.2013.313","article-title":"Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients","volume":"28","author":"Kumar","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.ccell.2024.05.026_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/blood-2020-140388","article-title":"Continued Improvement in Survival of Patients with Newly Diagnosed Multiple Myeloma (MM)","volume":"136","author":"Nandakumar","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2024.05.026_bib4","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1038\/s41375-019-0435-7","article-title":"Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy","volume":"33","author":"Gandhi","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.ccell.2024.05.026_bib5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrc3257","article-title":"The genetic architecture of multiple myeloma","volume":"12","author":"Morgan","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2024.05.026_bib6","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/ni1357","article-title":"Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination","volume":"7","author":"Klein","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ccell.2024.05.026_bib7","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature07064","article-title":"IRF4 addiction in multiple myeloma","volume":"454","author":"Shaffer","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2024.05.026_bib8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1244851","article-title":"Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells","volume":"343","author":"Kronke","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.ccell.2024.05.026_bib9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1126\/science.1244917","article-title":"The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins","volume":"343","author":"Lu","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.ccell.2024.05.026_bib10","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1182\/blood.2020007081","article-title":"Multiple cereblon genetic changes are associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma","volume":"137","author":"Gooding","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2024.05.026_bib11","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1038\/s41375-021-01373-4","article-title":"Mutations in CRBN and other cereblon pathway genes are infrequently associated with acquired resistance to immunomodulatory drugs","volume":"35","author":"Jones","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.ccell.2024.05.026_bib12","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.3437","article-title":"Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9","volume":"34","author":"Doench","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2024.05.026_bib13","doi-asserted-by":"crossref","first-page":"5469","DOI":"10.1038\/s41467-022-33142-x","article-title":"Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma","volume":"13","author":"Yang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2024.05.026_bib14","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12859-016-1015-8","article-title":"BAGEL: a computational framework for identifying essential genes from pooled library screens","volume":"17","author":"Hart","year":"2016","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.ccell.2024.05.026_bib15","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/s43018-023-00550-x","article-title":"Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias","volume":"4","author":"de Matos Simoes","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ccell.2024.05.026_bib16","article-title":"Bromodomain inhibition of the transcriptional coactivators CBP\/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma","volume":"5","author":"Conery","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.ccell.2024.05.026_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3324\/haematol.2018.191262","article-title":"DOT1L inhibition blocks multiple myeloma cell proliferation by suppressing IRF4-MYC signaling","volume":"104","author":"Ishiguro","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.ccell.2024.05.026_bib18","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1091\/mbc.E15-12-0844","article-title":"An improved smaller biotin ligase for BioID proximity labeling","volume":"27","author":"Kim","year":"2016","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ccell.2024.05.026_bib19","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.cell.2018.09.032","article-title":"Modular Organization and Assembly of SWI\/SNF Family Chromatin Remodeling Complexes","volume":"175","author":"Mashtalir","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2024.05.026_bib20","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1126\/science.abf8705","article-title":"Chromatin landscape signals differentially dictate the activities of mSWI\/SNF family complexes","volume":"373","author":"Mashtalir","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ccell.2024.05.026_bib21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ymeth.2008.06.014","article-title":"Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay","volume":"45","author":"Soderberg","year":"2008","journal-title":"Methods"},{"key":"10.1016\/j.ccell.2024.05.026_bib22","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.21856","article-title":"An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites","volume":"6","author":"Skene","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.ccell.2024.05.026_bib23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41571-020-0357-3","article-title":"The SWI\/SNF complex in cancer - biology, biomarkers and therapy","volume":"17","author":"Mittal","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ccell.2024.05.026_bib24","article-title":"Genomic Basis of Multiple Myeloma Subtypes from the MMRF CoMMpass Study","author":"Skerget","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.ccell.2024.05.026_bib25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s13059-021-02540-7","article-title":"Chronos: a cell population dynamics model of CRISPR experiments that improves inference of gene fitness effects","volume":"22","author":"Dempster","year":"2021","journal-title":"Genome Biol."},{"key":"10.1016\/j.ccell.2024.05.026_bib26","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.18632\/oncotarget.653","article-title":"Recurrent targets of aberrant somatic hypermutation in lymphoma","volume":"3","author":"Khodabakhshi","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.ccell.2024.05.026_bib27","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1038\/s41375-020-0919-5","article-title":"Frequent mutations in the amino-terminal domain of BCL7A impair its tumor suppressor role in DLBCL","volume":"34","author":"Balinas-Gavira","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.ccell.2024.05.026_bib28","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1182\/blood-2021-153462","article-title":"Universally Observed Loss of BCL7A Allows Activation of IRF4 and Its Transcriptional Activity in Multiple Myeloma Cells","volume":"138","author":"Chakraborty","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2024.05.026_bib29","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1038\/s41375-019-0438-4","article-title":"Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice","volume":"33","author":"Han","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.ccell.2024.05.026_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.705848","article-title":"Brg1 Supports B Cell Proliferation and Germinal Center Formation Through Enhancer Activation","volume":"12","author":"Schmiedel","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ccell.2024.05.026_bib31","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1084\/jem.134.1.188","article-title":"Peyer's patches: an enriched source of precursors for IgA-producing immunocytes in the rabbit","volume":"134","author":"Craig","year":"1971","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2024.05.026_bib32","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/bioinformatics\/btv612","article-title":"LOLA: enrichment analysis for genomic region sets and regulatory elements in R and Bioconductor","volume":"32","author":"Sheffield","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2024.05.026_bib33","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1084\/jem.20140425","article-title":"The transcription factors IRF8 and PU.1 negatively regulate plasma cell differentiation","volume":"211","author":"Carotta","year":"2014","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2024.05.026_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004821","article-title":"Ups and Downs of Poised RNA Polymerase II in B-Cells","volume":"12","author":"Dao","year":"2016","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ccell.2024.05.026_bib35","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-021-04246-z","article-title":"Targeting SWI\/SNF ATPases in enhancer-addicted prostate cancer","volume":"601","author":"Xiao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2024.05.026_bib36","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/gcc.20668","article-title":"A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma: an integrated genomics approach reveals a wide gene dosage effect","volume":"48","author":"Agnelli","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ccell.2024.05.026_bib37","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/s41375-020-01078-0","article-title":"The transcription factor IRF4 represses proapoptotic BMF and BIM to licence multiple myeloma survival","volume":"35","author":"Fedele","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.ccell.2024.05.026_bib38","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1182\/blood-2005-11-013458","article-title":"The molecular classification of multiple myeloma","volume":"108","author":"Zhan","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2024.05.026_bib39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41375-018-0196-8","article-title":"A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis","volume":"33","author":"Walker","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.ccell.2024.05.026_bib40","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1182\/blood.2020008346","article-title":"del(17p) without TP53 mutation confers a poor prognosis in intensively treated newly diagnosed patients with multiple myeloma","volume":"137","author":"Corre","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2024.05.026_bib41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41586-018-0290-0","article-title":"A multiprotein supercomplex controlling oncogenic signalling in lymphoma","volume":"560","author":"Phelan","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2024.05.026_bib42","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccr.2012.05.024","article-title":"Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma","volume":"21","author":"Yang","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2024.05.026_bib43","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1200\/JCO.2009.26.3947","article-title":"Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab","volume":"28","author":"Barrans","year":"2010","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2024.05.026_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2014.13","article-title":"Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients","volume":"4","author":"Walker","year":"2014","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.ccell.2024.05.026_bib45","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/leu.2014.70","article-title":"Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma","volume":"28","author":"Affer","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.ccell.2024.05.026_bib46","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.1158\/1078-0432.CCR-21-0005","article-title":"The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma","volume":"27","author":"Sharma","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2024.05.026_bib47","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1158\/1078-0432.CCR-20-2283","article-title":"Implications of MYC Rearrangements in Newly Diagnosed Multiple Myeloma","volume":"26","author":"Abdallah","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2024.05.026_bib48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cell.2012.08.026","article-title":"Transcriptional amplification in tumor cells with elevated c-Myc","volume":"151","author":"Lin","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2024.05.026_bib49","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41586-023-05780-8","article-title":"H3K4me3 regulates RNA polymerase II promoter-proximal pause-release","volume":"615","author":"Wang","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2024.05.026_bib50","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1158\/1078-0432.CCR-22-3668","article-title":"BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma","volume":"29","author":"Kurata","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2024.05.026_bib51","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/s41589-020-0645-3","article-title":"ARID2 is a pomalidomide-dependent CRL4(CRBN) substrate in multiple myeloma cells","volume":"16","author":"Yamamoto","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ccell.2024.05.026_bib52","doi-asserted-by":"crossref","first-page":"S677","DOI":"10.1016\/j.annonc.2023.09.2262","article-title":"1128P A phase I dose escalation and expansion study of FHD-286, a novel BRG1\/BRM (SMARCA4\/SMARCA2) inhibitor, for the treatment of metastatic uveal melanoma","volume":"34","author":"Patel","year":"2023","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ccell.2024.05.026_bib53","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1182\/blood-2023-178090","article-title":"Preliminary Results from a Phase 1 Dose Escalation Study of FHD-286, a Novel BRG1\/BRM (SMARCA4\/SMARCA2) Inhibitor, Administered As an Oral Monotherapy in Patients with Advanced Hematologic Malignancies","volume":"142","author":"Courtney","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2024.05.026_bib54","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41408-022-00695-5","article-title":"Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee","volume":"12","author":"Kumar","year":"2022","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.ccell.2024.05.026_bib55","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1158\/2643-3230.BCD-23-0061","article-title":"ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma","volume":"5","author":"Neri","year":"2024","journal-title":"Blood Cancer Discov."},{"key":"10.1016\/j.ccell.2024.05.026_bib56","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1158\/2643-3230.BCD-23-0062","article-title":"Transcriptional heterogeneity overcomes super-enhancer disrupting drug combinations in multiple myeloma","volume":"5","author":"Welsh","year":"2024","journal-title":"Blood Cancer Discov."},{"key":"10.1016\/j.ccell.2024.05.026_bib57","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1073\/pnas.1311846111","article-title":"High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells","volume":"111","author":"Mathews Griner","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2024.05.026_bib58","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1200\/JCO.2014.59.1503","article-title":"Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma","volume":"33","author":"Walker","year":"2015","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2024.05.026_bib59","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ccell.2024.02.010","article-title":"ARID1A orchestrates SWI\/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis","volume":"42","author":"Barisic","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2024.05.026_bib60","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ccell.2024.02.011","article-title":"SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisions","volume":"42","author":"Deng","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2024.05.026_bib61","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/j.ccell.2023.11.001","article-title":"Therapeutic targeting of EP300\/CBP by bromodomain inhibition in hematologic malignancies","volume":"41","author":"Nicosia","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2024.05.026_bib62","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1158\/2159-8290.CD-22-1401","article-title":"Targeting N-linked Glycosylation for the Therapy of Aggressive Lymphomas","volume":"13","author":"Scheich","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2024.05.026_bib63","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nbt.1630","article-title":"GREAT improves functional interpretation of cis-regulatory regions","volume":"28","author":"McLean","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2024.05.026_bib64","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2024.05.026_bib65","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2024.05.026_bib66","article-title":"Genomic Basis of Multiple Myeloma Subtypes from the MMRF CoMMpass Study","author":"Skerget","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.ccell.2024.05.026_bib67","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature09837","article-title":"Initial genome sequencing and analysis of multiple myeloma","volume":"471","author":"Chapman","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2024.05.026_bib68","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccell.2024.05.026_bib69","doi-asserted-by":"crossref","first-page":"W739","DOI":"10.1093\/nar\/gkac382","article-title":"SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples","volume":"50","author":"Ianevski","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2024.05.026_bib70","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41590-022-01413-w","article-title":"An epithelial cell-derived metabolite tunes immunoglobulin A secretion by gut-resident plasma cells","volume":"24","author":"Ceglia","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ccell.2024.05.026_bib71","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/nmeth.4396","article-title":"An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues","volume":"14","author":"Corces","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccell.2024.05.026_bib72","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ccell.2016.10.002","article-title":"A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm","volume":"30","author":"Ceribelli","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2024.05.026_bib73","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1158\/2643-3230.BCD-21-0063","article-title":"Overcoming Acquired Epigenetic Resistance to BTK Inhibitors","volume":"2","author":"Shaffer","year":"2021","journal-title":"Blood Cancer Discov."},{"key":"10.1016\/j.ccell.2024.05.026_bib74","doi-asserted-by":"crossref","first-page":"W670","DOI":"10.1093\/nar\/gkac312","article-title":"RSAT 2022: regulatory sequence analysis tools","volume":"50","author":"Santana-Garcia","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2024.05.026_bib75","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2024.05.026_bib76","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw0064","article-title":"Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening","volume":"11","author":"Lin","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ccell.2024.05.026_bib77","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610824002174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610824002174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T23:06:09Z","timestamp":1751929569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610824002174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":77,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1535610824002174"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2024.05.026","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IRF4 requires ARID1A to establish plasma cell identity in multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2024.05.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2024.06.012","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2024.06.006","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}